Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
Poland- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Poland15 clinical trials in Osielsko, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Comprehensive clinical trials focusing on moderate to severe plaque psoriasis, including studies evaluating new therapeutic approaches for patients with special area involvement.
Multiple innovative treatments being tested to improve patient outcomes and quality of life.
Advanced research into nonsegmental vitiligo treatments, exploring both oral medications and systemic therapies for long-term management.
Focused on developing sustainable treatment options for vitiligo patients.
Investigating treatments for various skin conditions including chronic hand eczema and alopecia areata.
Comprehensive research aimed at addressing challenging dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.